A Pharmaceutical Formulation as a Claim Term Cannot “Target” a Plasma Concentration-Time Profile Under 35 U.S.C. § 112: A Lesson from Horizon Pharma, Inc. v. Dr. Reddy's Laboratories Inc.

Biotechnology Law Report, Ahead of Print.

Source: Biotechnology Law Report - March 3, 2022 Category: Medical Law Authors: PING-HSUN CHEN Source Type: research